Clostridium difficile infection in patients with end stage renal disease. Is it preventable?

Lis, Łukasz; Konieczny, Andrzej; Żłobicka, Kinga; Witkiewicz, Wojciech; Hruby, Zbigniew

doi:10.15761/nrd.1000153

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Mimo to według raportu Polska należała do krajów o niskiej częstości wykonywania testów w kierunku Clostridioides difficile. Zakażenia układu pokarmowego wywołane tą bakterią u pacjentów hospitalizowanych zwiększają ryzyko zgonu, a także powodują wydłużenie czasu trwania hospitalizacji i kosztów leczenia (24). Większość przypadków odnotowuje się jednak wśród pacjentów niehospitalizowanych, co może mieć związek z powszechnym krążeniem bakterii w środowisku i zanieczyszczeniem nią żywności (25,26).…”

Section: Results and Their Discussionunclassified

“…Despite this, according to the report, Poland was among the countries with a low frequency of tests for Clostridioides difficile. Infections of the digestive system with this bacterium in hospitalized patients increase the risk of death and also prolong the duration of hospitalization and treatment costs (24). However, most cases are recorded among nonhospitalized patients and may be related to the widespread circulation of bacteria in the environment and with food contamination (25,26).…”

Section: Results and Their Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Infectious diseases in Poland in 2021

Rosińska,

Czarkowski,

Sadkowska-Todys

2024

Przegl Epidemiol

View full text Add to dashboard Cite

OBJECTIVE OF THE WORK. As 2021 was the second year of COVID-19 pandemic we expect the continuous impact of the pandemic on other infectious diseases. We aimed at reviewing the national infectious surveillance data based on available surveillance reports (Epidemiological Chronicle) to summarize the infectious disease situation in 2021. MATERIAL AND METHODS. National infectious disease surveillance system collects mandatory notifications from physicians and laboratories as well as epidemiological investigation reports prepared by State Sanitary Inspection, where relevant. We also include mortality data based on the reports of Statistics Poland office. RESULTS AND DISCUSSION. In 2021, there were 2,852,789 cases of COVID-19 reported, corresponding to the incidence of 7475.4 per 100,000 and 90,126 deaths related to COVID-19. For most of diseases the incidence remained lower than before the pandemic. This included influenzea and influenzea-like illness incidence (- 5.4% vs 2020 and – 37.6% vs median 2015-2019) and tuberculosis incidence (+9.3% vs 2020 and -35.9% vs median 2015-2019). The incidence was lower than in 2020 for: pertussis (-75.7%), measles (-54.9%), rubella (48.7%), mumps (-16.4%), chickenpox (-19.0%) or H. influenzea invasive disease (-33.0%). A notable exception to these trends was Clostridium difficile intestinal infections incidence, which was higher by 88.2% from the 2015-2019 median with 21,157 case and 1,120 fatalities reported in 2021. There was also an almost 4-fold increase in norovirus infections incidence. The number of chronic hepatitis infections diagnoses were substantially lower than median for 2015-2019 (-53.7% for HBV and – 68.8% for HCV). The COVID-19 pandemic still played the crucial role as a public health problem, but its impact on other infectious diseases was less clear than in 2020. The reduction in the number of registered cases was with likely attributable to non-pharmaceutic interventions and to delays in registration due to reduced public health resources.

show abstract

Section: Results and Their Discussionunclassified

Section: Results and Their Discussionmentioning

confidence: 99%